GlycoMimetics Inc (NAS:GLYC)
$ 0.3131 -0.0079 (-2.46%) Market Cap: 20.19 Mil Enterprise Value: 6.06 Mil PE Ratio: 0 PB Ratio: 1.78 GF Score: 30/100

Q1 2023 GlycoMimetics Inc Earnings Call Transcript

May 03, 2023 / 12:30PM GMT
Release Date Price: $1.36 (-3.55%)
Operator

Good morning, and thank you for joining the GlycoMimetics Q1 2023 Earnings Call. (Operator Instructions)

I would now like to hand -- turn the call over to Christian Dinneen-Long, Company Counsel at GlycoMimetics. Please go ahead.

Christian B. Dinneen;Long
GlycoMimetics, Inc. - General Counsel & Company Secretary

Good morning. Today, we will review our business updates and financial results for the quarter ended March 31, 2023. The press release we issued this morning is available on the company's website at glycomimetics.com. This call is being recorded, and a dial-in phone replay will be available for 24 hours after the close of the call. The webcast replay will also be available for 30 days in the Investors section of our website.

Joining me on the call today from GlycoMimetics are Harout Semerjian, Chief Executive Officer; Brian Hahn, Chief Financial Officer; and Dr. Edwin Rock, Chief Medical Officer.

Today's call will include forward-looking statements based on our current expectations. Forward-looking

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot